000 | 01937 a2200517 4500 | ||
---|---|---|---|
005 | 20250517091754.0 | ||
264 | 0 | _c20170117 | |
008 | 201701s 0 0 eng d | ||
022 | _a1815-7920 | ||
024 | 7 |
_a10.5588/ijtld.15.0463 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMok, Y | |
245 | 0 | 0 |
_aDo we need transbronchial lung biopsy if we have bronchoalveolar lavage Xpert® MTB/RIF? _h[electronic resource] |
260 |
_bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _cMay 2016 |
||
300 |
_a619-24 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibiotics, Antitubercular _xtherapeutic use |
650 | 0 | 4 | _aBacteriological Techniques |
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 |
_aBronchoalveolar Lavage Fluid _xmicrobiology |
650 | 0 | 4 |
_aDNA, Bacterial _xgenetics |
650 | 0 | 4 |
_aDrug Resistance, Bacterial _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMolecular Diagnostic Techniques |
650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aRifampin _xtherapeutic use |
650 | 0 | 4 |
_aSputum _xmicrobiology |
650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdiagnosis |
700 | 1 | _aTan, T Y | |
700 | 1 | _aTay, T R | |
700 | 1 | _aWong, H S | |
700 | 1 | _aTiew, P Y | |
700 | 1 | _aKam, J W | |
700 | 1 | _aSiao, C | |
773 | 0 |
_tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _gvol. 20 _gno. 5 _gp. 619-24 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.5588/ijtld.15.0463 _zAvailable from publisher's website |
999 |
_c25931525 _d25931525 |